TNF and COVID-19: The generation of NOX-dependent ROS elevates TNF-α, transforming growth factor-beta 1 (TGF-β1), ATII, and plasminogen activator inhibitor-1 (PAI-1), all of which are increased in COVID-19 patients [24, 27–30].